Apparently, in the Philippines, the use of ivermectin for human consumption (more than likely associated with SARS-CoV-2, the virus behind COVID-19) is progressing despite the overt tensions between those elements in society for its use against COVID-19 now versus those that suggest ever more clinical trials data is necessary. This movement is evidenced recently by the movement within the Philippines Food and Drug Administration (FDA) as Director-General Eric Domingo just on Friday acknowledged that the regulatory body issued a certificate of product registration or CPR to Lloyd Laboratories for the production and commercial sale of the product in the southeastern...